Holen Sie sich die Stockscreener-App
44.86
1.95%
0.86
Handel nachbörslich:
44.86
Schlusskurs vom Vortag:
$44.00
Offen:
$43.76
24-Stunden-Volumen:
909.49K
Relative Volume:
2.23
Marktkapitalisierung:
$1.39B
Einnahmen:
$1.32B
Nettoeinkommen (Verlust:
$110.20M
KGV:
12.67
EPS:
3.5417
Netto-Cashflow:
$148.24M
1W Leistung:
-5.28%
1M Leistung:
-6.79%
6M Leistung:
-22.23%
1J Leistung:
-36.28%
1-Tages-Spanne:
$43.00
$44.88
1-Wochen-Bereich:
$43.00
$48.19
52-Wochen-Spanne:
$42.50
$78.00
Conmed Corp Stock (CNMD) Company Profile
Firmenname
Conmed Corp
Sektor
Branche
Telefon
727-214-2974
Adresse
11311 CONCEPT BOULEVARD, LARGO, NY
Vergleichen Sie CNMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
44.86 | 1.36B | 1.32B | 110.20M | 148.24M | 3.5417 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-12 | Herabstufung | Needham | Buy → Hold |
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-02-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-01 | Bestätigt | Needham | Buy |
| 2023-05-22 | Eingeleitet | CL King | Buy |
| 2023-03-27 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-10-06 | Hochstufung | Needham | Hold → Buy |
| 2021-07-15 | Eingeleitet | UBS | Buy |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2019-11-26 | Herabstufung | Needham | Buy → Hold |
| 2019-11-12 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-31 | Bestätigt | Needham | Buy |
| 2019-10-04 | Bestätigt | Needham | Buy |
| 2019-08-22 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | Eingeleitet | Stifel | Buy |
| 2019-04-16 | Bestätigt | Needham | Buy |
| 2019-01-23 | Bestätigt | Needham | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-08-07 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-04-26 | Bestätigt | Needham | Buy |
| 2018-02-01 | Bestätigt | Needham | Buy |
| 2017-07-27 | Bestätigt | Needham | Buy |
| 2017-04-27 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | Bestätigt | Needham | Buy |
| 2016-11-18 | Bestätigt | Needham | Buy |
| 2016-07-28 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | Bestätigt | Needham | Buy |
| 2015-10-22 | Bestätigt | Northland Capital | Market Perform |
Alle ansehen
Conmed Corp Aktie (CNMD) Neueste Nachrichten
How risky is CONMED Corporation (EC8) stock compared to peersJuly 2025 Gainers & Growth Focused Entry Reports - newser.com
Will CONMED Corporation stock announce special dividendTrade Performance Summary & Precise Buy Zone Tips - newser.com
Is CONMED Corporation reversing from oversold territoryJuly 2025 PreEarnings & Verified Swing Trading Watchlists - newser.com
Is CONMED Corporation stock positioned for digital transformationMarket Trend Review & Expert-Curated Trade Recommendations - newser.com
How CONMED Corporation stock compares to market leadersWeekly Earnings Recap & Fast Exit/Entry Strategy Plans - newser.com
Will CONMED Corporation stock enhance shareholder valueWeekly Investment Recap & Community Supported Trade Ideas - newser.com
How CONMED Corporation (EC8) stock behaves under inflation pressureIPO Watch & Free Fast Entry Momentum Trade Alerts - newser.com
How CONMED Corporation stock moves in volatile trading sessions2025 Valuation Update & Real-Time Stock Movement Alerts - newser.com
How CONMED Corporation stock performs in weak economyMarket Trend Review & Low Risk Profit Maximizing Plans - newser.com
Will CONMED Corporation stock outperform benchmarksJuly 2025 Summary & Low Drawdown Trading Strategies - newser.com
Is CONMED Corporation (EC8) stock attractive for dividend growthJuly 2025 Breakouts & High Yield Equity Trading Tips - newser.com
How robust is CONMED Corporation (EC8) stock financial positionJuly 2025 Volume & Daily Growth Stock Tips - newser.com
Is CONMED Corporation stock a buy before product launchesDividend Hike & High Accuracy Investment Signals - newser.com
CONMED (NYSE:CNMD) Shares Gap DownHere's Why - MarketBeat
Is CONMED Corporation stock safe for conservative investors2025 Trading Volume Trends & Real-Time Volume Surge Alerts - newser.com
Ranking CONMED Corporation among high performing stocks via toolsWeekly Investment Recap & Stock Timing and Entry Methods - newser.com
Is CONMED Corporation (EC8) stock undervalued historicallyWeekly Profit Summary & Daily Volume Surge Trade Alerts - newser.com
CONMED (CNMD) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Will CONMED Corporation outperform the market2025 Market WrapUp & Expert-Curated Trade Recommendations - newser.com
Is CONMED Corporation (EC8) stock worth holding before Fed meetingEarnings Growth Report & Real-Time Volume Analysis - newser.com
Why CONMED Corporation stock appeals to analystsJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
Is CONMED Corporation stock a buy on dipsQuarterly Profit Report & Daily Profit Focused Screening - newser.com
Finanzdaten der Conmed Corp-Aktie (CNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):